Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:259349.
doi: 10.1155/2012/259349. Epub 2012 Apr 10.

Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders

Affiliations
Review

Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders

Lie-Hang Shen et al. J Biomed Biotechnol. 2012.

Abstract

Dopamine is the most intensely studied monoaminergic neurotransmitter. Dopaminergic neurotransmission plays an important role in regulating several aspects of basic brain function, including motor, behavior, motivation, and working memory. To date, there are numerous positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers available for targeting different steps in the process of dopaminergic neurotransmission, which permits us to quantify dopaminergic activity in the living human brain. Degeneration of the nigrostriatal dopamine system causes Parkinson's disease (PD) and related Parkinsonism. Dopamine is the neurotransmitter that has been classically associated with the reinforcing effects of drug abuse. Abnormalities within the dopamine system in the brain are involved in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Dopamine receptors play an important role in schizophrenia and the effect of neuroleptics is through blockage of dopamine D(2) receptors. This review will concentrate on the radiotracers that have been developed for imaging dopaminergic neurons, describe the clinical aspects in the assessment of neuropsychiatric disorders, and suggest future directions in the diagnosis and management of such disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of various radiotracers for the assessment of dopamine synthesis, reuptake sites, and receptors.
Figure 1
Figure 1
Chemical structure of various radiotracers for the assessment of dopamine synthesis, reuptake sites, and receptors.
Figure 2
Figure 2
Dopamine transporter (DAT) imaging with 99mTc-TRODAT-1 and dopamine D2 receptor imaging with 123I-IBZM of healthy volunteer and patients with Parkinson's disease (PD), multiple-system atrophy (MSA), and progressive supranuclear palsy (PSP). The striatal DAT uptakes were significantly decreased in patients with PD, MSA, and PSP, whereas the dopamine D2 receptor uptakes were mildly decreased in patients with PD, MSA, and PSP.

References

    1. Wong DF, Gründer G, Brasic JR. Brain imaging research: does the science serve clinical practice? International Review of Psychiatry. 2007;19(5):541–558. - PubMed
    1. Metter FA, Guiberteau MJ. Essentials of Nuclear Medicine Imaging. 5th edition. chapter 1. Saunders, Elsevier; 2006. Radioactivity, radionuclides, and radiopharmaceuticals; pp. 1–13.
    1. Metter FA, Guiberteau MJ. Essentials of Nuclear Medicine Imaging. 5th edition. chapter 13. Saunders, Elsevier; 2006. Positron emission tomography (PET) imaging; pp. 359–423.
    1. Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;219(2):316–333. - PubMed
    1. Fumita M, Innis RB. Neuropsychopharmacology: The Fifth Generation of Progress. 1st edition. Philadelphia, Pa, USA: Lippincott Williams & Wilkins; 2002.

Publication types

MeSH terms

Substances